Preventing the Progression of Multiple Sclerosis: Early Rehabilitative Treatment and Multimodal Assessment - Part A
1 other identifier
observational
80
1 country
3
Brief Summary
Motor performance of people with Multiple Sclerosis (PwMS) can decline since the onset of the disease. Longitudinal studies are needed to detect early worsening in mobility and balance using wearable devices for activity tracking and neurophysiological techniques for investigating brain functional adaptation. Similarly, neurophysiological assessment can provide evidences on the integrity of brain motor networks and mechanisms underlying cortical plasticity in the early disease phase, potentially providing a set of reliable prognostic factors of disease progression in early diagnosed PwMS. Furthermore, disease progression might be delayed using physical activity, which is effective in PwMS with moderate disability to ameliorate mobility and promoting brain reorganization and seems promising also for PwMS in the early stages of the disease. Functional Near-Infrared Spectroscopy (fNIRS) measures blood flow which accompanies neuronal activity, thus, it can provide spatial information about changes in cortical activation patterns and it could represent a useful tool for studying the effect of exercise on cortical plasticity. The aims of the study in non-disabled PwMS are: 1) a) to assess the presence of subclinical balance and walking impairments using wearable devices and multimodal gait analysis and b) to investigate cortical activity during exercise, 2) to define prognostic factors associated to disease progression and 3) to study the efficacy of physical activity in preventing the worsening of mobility and stimulating brain functional adaptation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2022
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 11, 2023
CompletedFirst Posted
Study publicly available on registry
January 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 23, 2024
July 1, 2023
2 years
September 11, 2023
January 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Six Minute Walk test (SMWT)
Assesses distance in meters walked over 6 minutes as a sub-maximal test of endurance capacity.
Baseline, Follow-up 1year, Follow-up 2year
Secondary Outcomes (3)
Concentration of oxygenated hemoglobin (Delta oxyHb)
Baseline, Follow-up 1year, Follow-up 2year
Expanded Disability Status Scale (EDSS)
Baseline, Follow up 1year, Follow up 2year
Regularity of gait
Baseline, Follow-up 1year, Follow-up 2yearr
Other Outcomes (16)
Dual Task Cost
Baseline, Follow-up 1year, Follow-up 2year
Dual-task Impact on Daily-living Activities Questionnaire (DIDA-Q)
Baseline, Follow-up 1year, Follow-up 2year
Timed 25 foot walk (T25FWT)
Baseline, Follow-up 1year, Follow-up 2year
- +13 more other outcomes
Interventions
Observation of the natural course of the disease
Eligibility Criteria
Participants will be recruited within Persons with Multiple Sclerosis attending the clinical centers for routine medical visits willing to participate to the study after the presentation of the information sheet.
You may qualify if:
- Age \> 17 years
- Stable disease course (without worsening over 1 point at the EDSS in the last 3 months)
- Expanded Disability Status Scale (EDSS) \<2.5
You may not qualify if:
- Major depression
- Mini-Mental State Examination \< 27
- Other cardiovascular or orthopedic diseases that interfere with physical exercise
- Undefined or not confirmed diagnosis of MS (Polman criteria)
- Progressive course of the disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione Don Carlo Gnocchi Onluslead
- IRCCS San Raffaelecollaborator
- Azienda Sanitaria Locale di Cagliaricollaborator
Study Sites (3)
Ospedale Binaghi ASL Cagliari
Cagliari, Italy
IRCCS Ospedale San Raffele
Milan, 20100, Italy
IRCCS Fondazione Don Carlo Gnocchi
Milan, 20148, Italy
Related Publications (1)
Gervasoni E, Torchio A, Bertoni R, Chieffo R, Rocca MA, Pau M, Cocco E, Morozumi T, Filippi M, Cattaneo D, Rovaris M. Beyond EDSS: multidomain impairments are detectable and associated with walking disorders in low-disabled people with multiple sclerosis. J Neurol. 2025 May 18;272(6):404. doi: 10.1007/s00415-025-13128-7.
PMID: 40382461DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marco Rovaris, MD
IRCCS Fondazione Don Carlo Gnocchi
- PRINCIPAL INVESTIGATOR
Raffaella Chieffo, MD
IRCCS Ospedale San Raffaele
- PRINCIPAL INVESTIGATOR
Eleonora Cocco, MD
Ospedale Binaghi ASL Cagliari, Sardegna
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2023
First Posted
January 23, 2024
Study Start
July 1, 2022
Primary Completion
July 7, 2024
Study Completion
December 1, 2025
Last Updated
January 23, 2024
Record last verified: 2023-07